Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 9/20 | 0.45 |
| ▸ | MMP1 | P03956 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | STS | P08842 | 4/20 | 0.42 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.40 |
| ▸ | NR1D1 | P20393 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.39 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6893849 | 0.83 | MMP13 (0.46) | MMP13MMP1KDM4EMAPTSTS | |
| SCHEMBL27527619 | 0.80 | MAPT (0.43) | MAPT | |
| SCHEMBL2775887 | 0.67 | STS (0.46) | KDM4EMAPTSTSNR1D1CNR1 | |
| SCHEMBL6888393 | 0.67 | POLB (0.52) | KDM4EMAPTGPR119 | |
| SCHEMBL4388695 | 0.66 | F10 (0.54) | — | |
| SCHEMBL3155704 | 0.66 | STS (0.56) | KDM4ESTSNR1D1GPR119 | |
| SCHEMBL2420724 | 0.66 | SMN1; SMN2 (0.58) | KDM4EMAPTSTS | |
| SCHEMBL6896849 | 0.66 | KDM4E (0.41) | KDM4EMAPTGPR119 | |
| SCHEMBL5727730 | 0.66 | MMP13 (0.54) | MMP13MMP1KDM4EMAPTSTS | |
| SCHEMBL3083337 | 0.66 | KDM4E (0.58) | KDM4EMAPTSTSGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1290254-A | Sulfonamide derivatives process for producing the same and utilization thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-04-04 | — | — | CN | disclosed |